VirtualScopics

VirtualScopics is a specialized contract research organization (CRO) that provides quantitative imaging biomarker analysis for clinical trials. The company utilizes advanced medical imaging technologies, including MRI, CT, and PET, to provide objective data on drug efficacy and safety. Their proprietary software platform enables automated and semi-automated measurement of anatomical and physiological changes in patients. VirtualScopics primarily serves the pharmaceutical and biotechnology sectors, with a strong focus on oncology, musculoskeletal diseases, and neurology. Originally a spin-off from the University of Rochester, the company was acquired by BioTelemetry in 2016 to enhance its clinical research service offerings. It is currently integrated into the Philips healthcare portfolio following Philips' acquisition of BioTelemetry.